Drug Interactions between deflazacort and methylprednisolone
This report displays the potential drug interactions for the following 2 drugs:
- deflazacort
- methylprednisolone
Interactions between your drugs
No interactions were found between deflazacort and methylprednisolone. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
deflazacort
A total of 576 drugs are known to interact with deflazacort.
- Deflazacort is in the drug class glucocorticoids.
- Deflazacort is used to treat Duchenne Muscular Dystrophy.
methylprednisolone
A total of 625 drugs are known to interact with methylprednisolone.
- Methylprednisolone is in the drug class glucocorticoids.
-
Methylprednisolone is used to treat the following conditions:
- Allergic Rhinitis
- Allergies
- Asthma
- Asthma, acute
- Asthma, Maintenance
- Atopic Dermatitis
- Back Pain
- Congenital Adrenal Hyperplasia
- Dermatologic Lesion
- Gout, Acute
- Immunosuppression
- Inflammatory Conditions
- Lupus Nephritis (off-label)
- Multiple Sclerosis
- Nephropathy (off-label)
- Neuralgia
- Osteoarthritis
- Plaque Psoriasis
- Psoriasis
- Rheumatoid Arthritis
- Shock
- Transverse Myelitis
- Ulcerative Colitis, Active
Drug and food interactions
methylPREDNISolone food
Applies to: methylprednisolone
Grapefruit juice may increase the blood levels of certain medications such as methylPREDNISolone. You may want to limit your consumption of grapefruit and grapefruit juice during treatment with methylPREDNISolone. However, if you have been regularly consuming grapefruit or grapefruit juice with the medication, then it is advisable for you to talk with your doctor before changing the amounts of these products in your diet, as this may alter the effects of your medication. Contact your doctor if your condition changes or you experience increased side effects. Orange juice is not expected to interact.
deflazacort food
Applies to: deflazacort
Do not take deflazacort with grapefruit juice. Grapefruit juice may increase the blood levels of the active component of deflazacort. This may increase the risk and/or severity of side effects such as swelling, weight gain, electrolyte abnormalities, high blood pressure, high blood glucose, muscle weakness, depression, mood swings, acne, thinning skin, stretch marks, easy bruising, bone density loss, cataracts, glaucoma, menstrual irregularities, excessive growth of facial or body hair, and abnormal distribution of body fat, especially in the face, neck, back, and waist. Other side effects that may occur include decreased ability to fight infections, increased risk of developing infections, and inadequate response to stress such as infection, surgery, trauma, or a severe asthma attack. Children may experience a reduced growth rate during chronic use. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.
Cortisones
Therapeutic duplication
The recommended maximum number of medicines in the 'cortisones' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'cortisones' category:
- deflazacort
- methylprednisolone
Note: In certain circumstances, the benefits of taking this combination of drugs may outweigh any risks. Always consult your healthcare provider before making changes to your medications or dosage.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.